Julie Bennett

23A Mein Street
Newtown, WGN 6021, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Whitia Kia Ora: a culturally responsive model of Bicillin L-A® delivery for people with rheumatic fever in the Waikato region of Aotearoa New Zealand.

Whitia Kia Ora: a culturally responsive model of Bicillin L-A® delivery for people with rheumatic fever in the Waikato region of Aotearoa New Zealand.

Journal: The New Zealand medical journal

Published: August 13, 2026

Stuffy nights: elevated bedroom carbon dioxide concentrations indicate inadequate ventilation in Wellington homes.

Stuffy nights: elevated bedroom carbon dioxide concentrations indicate inadequate ventilation in Wellington homes.

Journal: The New Zealand medical journal

Published: June 25, 2026

The COVID-19 pandemic and acute rheumatic fever inequities, Aotearoa New Zealand, 2020-2022.

The COVID-19 pandemic and acute rheumatic fever inequities, Aotearoa New Zealand, 2020-2022.

Journal: The New Zealand medical journal

Published: June 25, 2026

Group C/G Streptococcal Pharyngitis and Acute Rheumatic Fever in Auckland, New Zealand, 2010-2016.

Group C/G Streptococcal Pharyngitis and Acute Rheumatic Fever in Auckland, New Zealand, 2010-2016.

Journal: Journal of paediatrics and child health

Published: February 13, 2026

CXCR3 is associated with T-cell-induced heart damage in acute rheumatic fever.

CXCR3 is associated with T-cell-induced heart damage in acute rheumatic fever.

Journal: Nature communications

Published: August 28, 2025

Prevention of rheumatic heart disease in New Zealand: High-dose subcutaneous benzathine penicillin is cost-saving compared with traditional intramuscular injections.

Prevention of rheumatic heart disease in New Zealand: High-dose subcutaneous benzathine penicillin is cost-saving compared with traditional intramuscular injections.

Journal: IJID regions

Published: August 06, 2025

Māori and Pacific People's perspectives on Group A Streptococcus vaccine development and delivery in Aotearoa, New Zealand.

Māori and Pacific People's perspectives on Group A Streptococcus vaccine development and delivery in Aotearoa, New Zealand.

Journal: PLOS global public health

Published: July 31, 2025

Pandemic mitigations reveal an association between superficial group A streptococcal infections and acute rheumatic fever incidence in Auckland New Zealand.

Pandemic mitigations reveal an association between superficial group A streptococcal infections and acute rheumatic fever incidence in Auckland New Zealand.

Journal: Emerging microbes & infections

Published: July 24, 2025

Diverse diagnostic and management approaches for acute rheumatic fever in Australia and New Zealand: findings of a prospective clinical study.

Diverse diagnostic and management approaches for acute rheumatic fever in Australia and New Zealand: findings of a prospective clinical study.

Journal: BMJ open

Published: July 17, 2025

Subcutaneous injections of penicillin (SCIP): Convenient and effective treatment for Māori, Pacific Peoples and their families in preventing rheumatic heart disease.

Subcutaneous injections of penicillin (SCIP): Convenient and effective treatment for Māori, Pacific Peoples and their families in preventing rheumatic heart disease.

Journal: PLOS global public health

Published: June 29, 2025

Capturing the complete clinical spectrum and incidence of severe acute Group A Streptococcus (GAS) disease: a population-based study in Auckland, New Zealand.

Capturing the complete clinical spectrum and incidence of severe acute Group A Streptococcus (GAS) disease: a population-based study in Auckland, New Zealand.

Journal: The Lancet regional health. Western Pacific

Published: March 13, 2025

Epidemiology of skin infections in Auckland, New Zealand.

Epidemiology of skin infections in Auckland, New Zealand.

Journal: The New Zealand medical journal

Published: February 13, 2025

Showing 1-12 of 47

Last Updated: 09/26/2026